Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Stopped The Principal Investigator left the clinic and there was no one who could take over this study.

Conditions

• Cognitive Symptoms

Interventions

• DRUG: Rivastigmine

Sponsor

Novartis